Literature DB >> 21211638

One hundred years of allergen immunotherapy: time to ring the changes.

Stephen R Durham, Donald Y M Leung.   

Abstract

Mesh:

Year:  2011        PMID: 21211638     DOI: 10.1016/j.jaci.2010.11.032

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  10 in total

1.  Increased peanut-specific IgA levels in saliva correlate with food challenge outcomes after peanut sublingual immunotherapy.

Authors:  Michael Kulis; Katie Saba; Edwin H Kim; J Andrew Bird; Nikolas Kamilaris; Brian P Vickery; Herman Staats; A Wesley Burks
Journal:  J Allergy Clin Immunol       Date:  2012-01-10       Impact factor: 10.793

2.  Epigenetic modifications and improved regulatory T-cell function in subjects undergoing dual sublingual immunotherapy.

Authors:  Ravi S Swamy; Neha Reshamwala; Tessa Hunter; Soujanya Vissamsetti; Carah B Santos; Fuad M Baroody; Peter H Hwang; Elisabeth G Hoyte; Marco A Garcia; Kari C Nadeau
Journal:  J Allergy Clin Immunol       Date:  2012-06-05       Impact factor: 10.793

3.  Adherence to subcutaneous immunotherapy with aeroallergens in real-life practice during the COVID-19 pandemic.

Authors:  Osman Ozan Yeğit; Semra Demir; Derya Ünal; Müge Olgaç; Kadriye Terzioğlu; Deniz Eyice Karabacak; Can Tüzer; Vehbi Ayhan; Bahattin Çolakoğlu; Suna Büyüköztürk; Aslı Gelincik
Journal:  Allergy       Date:  2021-05-10       Impact factor: 14.710

Review 4. 

Authors:  Ludger Klimek; Oliver Pfaar; Margitta Worm; Karl-Christian Bergmann; Thomas Bieber; Roland Buhl; Jeroen Buters; Ulf Darsow; Thomas Keil; Jörg Kleine-Tebbe; Susanne Lau; Marcus Maurer; Hans Merk; Ralph Mösges; Joachim Saloga; Petra Staubach; Dagmar Poethig; Klaus Rabe; Uta Rabe; Claus Vogelmeier; Tilo Biedermann; Kirsten Jung; Wolfgang Schlenter; Johannes Ring; Adam Chaker; Wolfgang Wehrmann; Sven Becker; Norbert Mülleneisen; Katja Nemat; Wolfgang Czech; Holger Wrede; Randolf Brehler; Thomas Fuchs; Peter-Valentin Tomazic; Werner Aberer; Antje Fink-Wagner; Friedrich Horak; Stefan Wöhrl; Verena Niederberger-Leppin; Isabella Pali-Schöll; Wolfgang Pohl; Regina Roller-Wirnsberger; Otto Spranger; Rudolf Valenta; Mübecell Akdis; Cezmi Akdis; Karin Hoffmann-Sommergruber; Marek Jutel; Paolo Matricardi; François Spertini; Nikolai Khaltaev; Jean-Pierre Michel; Laurent Nicod; Peter Schmid-Grendelmeier; Eckard Hamelmann; Thilo Jakob; Thomas Werfel; Martin Wagenmann; Christian Taube; Jean Bousquet; Torsten Zuberbier; Christian Vogelberg; Michael Gerstlauer
Journal:  Allergo J       Date:  2020-05-08

5.  Allergen-specific immunotherapy practices and course of coronavirus disease 2019 (COVID-19) in patients during COVID-19.

Authors:  Merve Erkoç; Betül Özdel Öztürk; Dilşad Mungan; Derya Öztuna; Sevim Bavbek; Yavuz Selim Demirel; Ömür Aydın; Betül Ayşe Sin
Journal:  Asia Pac Allergy       Date:  2022-01-24

6.  ICS/LABA Combined With Subcutaneous Immunotherapy Modulates the Th17/Treg Imbalance in Asthmatic Children.

Authors:  Huan Dai; Rongying Zheng; Like Wang; Jinyi Wan; Yu Tong; Wei Zhao; Weixi Zhang
Journal:  Front Immunol       Date:  2022-03-10       Impact factor: 7.561

7.  Real-life adherence to subcutaneous immunotherapy: What has changed in the era of the COVID-19 pandemic.

Authors:  Ilkay Koca Kalkan; Hale Ates; Kurtulus Aksu; Selma Yesilkaya; Musa Topel; Dilek Cuhadar Ercelebi; Suleyman Turkyilmaz; Ali Oncul; Senay Demir
Journal:  World Allergy Organ J       Date:  2021-06-08       Impact factor: 4.084

8.  The rate of epinephrine administration associated with allergy skin testing in a suburban allergy practice from 1997 to 2010.

Authors:  David A Swender; Leah R Chernin; Chris Mitchell; Theodore Sher; Robert Hostoffer; Haig Tcheurekdjian
Journal:  Allergy Rhinol (Providence)       Date:  2012-12-12

9.  Ultra-short-course booster is effective in recurrent grass pollen-induced allergic rhinoconjunctivitis.

Authors:  O Pfaar; S Lang; U Pieper-Fürst; A Astvatsatourov; F Gerich; L Klimek; M F Kramer; Y Reydelet; K Shah-Hosseini; R Mösges
Journal:  Allergy       Date:  2017-09-05       Impact factor: 13.146

10.  Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement.

Authors:  Ludger Klimek; Marek Jutel; Cezmi Akdis; Jean Bousquet; Mübeccel Akdis; Claus Bachert; Ioana Agache; Ignacio Ansotegui; Anna Bedbrook; Sinthia Bosnic-Anticevich; Giorgio W Canonica; Tomas Chivato; Alvaro A Cruz; Wienia Czarlewski; Stefano Del Giacco; Hui Du; Joao A Fonseca; Yadong Gao; Tari Haahtela; Karin Hoffmann-Sommergruber; Juan-Carlos Ivancevich; Nikolai Khaltaev; Edward F Knol; Piotr Kuna; Desiree Larenas-Linnemann; Erik Melen; Joaquim Mullol; Robert Naclerio; Ken Ohta; Yoshitaka Okamoto; Liam O'Mahony; Gabrielle L Onorato; Nikos G Papadopoulos; Ruby Pawankar; Oliver Pfaar; Boleslaw Samolinski; Jurgen Schwarze; Sanna Toppila-Salmi; Mohamed H Shamji; Maria Teresa Ventura; Arunas Valiulis; Arzu Yorgancioglu; Paolo Matricardi; Torsten Zuberbier
Journal:  Allergy       Date:  2020-07       Impact factor: 14.710

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.